,20 on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcome Investigators background Guidelines propose classification of conventional blood pressure (CBP) into normotension (<120/<80 mm Hg), prehypertension (120-139/80-89 mm Hg), and hypertension (≥140/≥90 mm Hg).
The relationship between cardiovascular outcome and blood pressure (BP) is log linear, without a critical level above which the risk suddenly increases. 1 However, for the diagnosis and management of hypertension, clinicians need operational thresholds. 2, 3 Therefore, the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) 2 and the World Health Organization and the International Society of Hypertension (WHO-ISH) 3 proposed a classification of blood pressure based on conventional measurement into normal, prehypertensive, and hypertensive levels.
Ambulatory blood pressure (ABP) monitoring substantially refines the risk stratification in hypertensive patients 4 and in people randomly recruited from populations. 5, 6 Few studies [7] [8] [9] [10] have examined whether ABP measurement refines risk stratification to a similar extent within each of the categories of office blood pressure. However, these studies had a sample size that ranged from 591 9 to 942, 8 most included selected patients, [7] [8] [9] [10] and all but 1 9 had as outcome variables intermediary outcomes, such as left ventricular mass, 7 pulse wave velocity, 8 and carotid intima-media thickness. 10 To our knowledge, no previous studies have addressed risk stratification by ABP monitoring in large population cohorts across all categories of the conventional blood pressure (CBP) using hard fatal and nonfatal outcomes. To resolve this research question, we analyzed 7,826 untreated participants randomly recruited from 11 populations and enrolled in the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO). 11 
METHODS

Study population
At the time of writing this article, the IDACO database 11 included 11 randomly recruited population cohorts [12] [13] [14] [15] [16] [17] [18] [19] [20] and 12,148 participants with available data on conventional and ABP. Details on recruitment of the IDACO cohorts are given in Supplementary Table 1 . We excluded 4,322 participants because they were aged <18 years (n = 303), their CBP was not within the database (n = 248), their nighttime blood pressure had not been recorded (n = 1,367 14 ), they were taking antihypertensive drugs at baseline (n = 2,156), or their ABP recordings did not comply with recommended 21 and predefined 11 quality standards and covered fewer than 20 hours or included fewer than 10 daytime or 5 nighttime readings (n = 248). Thus, the total number of participants included in the present analysis totaled 7,826.
Blood pressure measurement
Methods used for conventional and ABP measurement are described in detail in the Expanded Methods section. CBP was the average of 2 consecutive readings obtained either at the person's home 14, [16] [17] [18] [19] or at an examination center. 13, 15, 20, 22 Portable monitors were programmed to obtain ABP readings at 30-minute intervals throughout the whole day 13, 20 or at intervals ranging from 15 minutes 22 to 30 minutes 15 during the daytime and from 30 minutes 22 to 60 minutes 15 at night.
We categorized CBP according to the JNC7 2 and WHO-ISH 3 guidelines. Normal blood pressure was a level <120 mm Hg systolic and 80 mm Hg diastolic. Prehypertension encompassed 120-139 mm Hg systolic or 80-89 mm Hg diastolic. Patients who had a blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic were classified as hypertensive. To categorize levels of ABP, we followed the guidelines of the European Societies of Cardiology and Hypertension. 23 Ambulatory hypertension was a 24-hour level of 130 mm Hg systolic or 80 mm Hg diastolic or more; for the daytime blood pressure, these thresholds were 135 mm Hg and 85 mm Hg, and for the nighttime blood pressure they were 120 mm Hg and 70 mm Hg, respectively. Sustained normotension and hypertension were a normal blood pressure or hypertension on both conventional and ambulatory measurement. Masked hypertension was ambulatory hypertension in participants with a normal CBP.
Other measurements
We used the questionnaires originally administered in each cohort to obtain information on each participant's medical history and smoking and drinking habits. Body mass index was measured as body weight, in kilograms, divided by height, in meters squared. We measured serum cholesterol and blood glucose by automated enzymatic methods. Diabetes mellitus was the use of antidiabetic drugs, a fasting blood glucose concentration of at least 7.0 mmol/L, [13] [14] [15] [16] 18, 19, 22 a random blood glucose concentration of at least 11.1 mmol/L, 13, 14, 17 a self-reported diagnosis, 14, 16, 17 or diabetes documented in practice or hospital records. 16 
Ascertainment of events
We ascertained vital status and the incidence of fatal and nonfatal diseases from the appropriate sources in each country, as described in previous publications. [24] [25] [26] Fatal and nonfatal stroke did not include transient ischemic attacks. Coronary events encompassed death from ischemic heart disease, sudden death, nonfatal myocardial infarction, and coronary revascularization. Cardiac events comprised coronary endpoints and fatal and nonfatal heart failure. The composite cardiovascular endpoint included all aforementioned endpoints plus cardiovascular mortality. In all outcome analyses, we only considered the first event within each category.
Statistical analysis
For database management and statistical analysis, we used SAS software, version 9.3 (SAS Institute, Cary, NC). For comparison of means and proportions, we applied the large-sample z test and the χ 2 statistic, respectively. In Cox regression, we adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular complications, and diabetes mellitus. To adjust for cohort, we pooled participants recruited in the framework of the European Project on Genes in Hypertension (Kraków, at KU Leuven University Library on http://ajh.oxfordjournals.org/ Downloaded from Novosibirsk, Padova, and Pilsen). 19 We ascertained that the proportional hazard assumption underlying the Cox regression models was fulfilled by testing the interaction between the blood pressure categories and follow-up time. For categorical analyses, we presented hazard ratios (HRs) as floating absolute risks and calculated their standard errors as described by Easton and colleagues. 27 This approach allows calculation of a 95% confidence interval (CI) for the relative risk in the reference group. 27 We compared HRs between groups by testing the significance of the appropriated interaction term. Statistical significance was an α level of <0.05 on 2-sided tests.
RESULTS
Baseline characteristics
The study population consisted of 5 Table 1 lists the characteristics of the study participants by these categories. Using conventional and daytime ABP measurement for cross-classification, the prevalence of masked hypertension was higher (P < 0.0001) among prehypertensive patients (n = 900; 29.3%) than those with normotension (n = 198; 7.5%). Supplementary Tables 1 and 2 and the Supplementary Results provide detailed information on the determinants of masked hypertension and their discriminative power in our untreated participants.
Incidence of events
In the overall study population, the median follow-up was 11.3 years (5th to 95th percentile interval, 2.6-18.2 years). Across centers, median follow-up ranged from 2.5 years (5th to 95th percentile interval, 2.3-2.6) in Jingning, China, to 17.8 years (16.6-18.2 years) in Dublin, Ireland. During 87,624 person-years of follow-up, 809 participants died (9.2/1,000 person-years) and 639 experienced a fatal or nonfatal cardiovascular complication (7.5/1,000 person-years). Mortality included 276 cardiovascular and 503 noncardiovascular deaths, 23 deaths from unknown causes, and 7 deaths due to renal failure. Considering cause-specific first cardiovascular events, the incidence of fatal and nonfatal stroke was 42 and 183, respectively. Cardiac events consisted of 39 fatal and 134 nonfatal cases of acute myocardial infarction, 45 deaths from ischemic heart diseases, 6 sudden deaths, 16 fatal and 96 nonfatal cases of heart failure, and 47 cases of surgical or percutaneous coronary revascularization.
Risk associated with categories of CBP
In the first step of our analyses, we assessed, as as internal validation of our dataset, whether as-expected risks increased across increasing categories of CBP. Rates of mortality and fatality combined with nonfatal events increased (P < 0.0001) with higher categories of CBP (Table 2) . With normotension as the reference (Table 2) , prehypertensive participants had a significantly higher risk of a composite cardiovascular endpoint (+41%; P = 0.01) and stroke (+92%; P = 0.02). With hypertension as the reference (Table 2 ), the risks of cardiovascular death (-28%; P = 0.01), a composite cardiovascular endpoint (-34%; P < 0.0001), a cardiac (-33%; P = 0.0007) or coronary (-27%; P = 0.02) event, or stroke (-47%; P < 0.0001) were significantly lower in prehypertensive participants.
Risks associated with ABP by categories of CBP
In the next step of our analyses, we assessed whether the ABP level measured on a continuous scale differentially contributed to risk stratification across increasing categories of the CBP. We expressed HRs for 5-mm Hg and 10-mm Hg increments in the ambulatory diastolic and systolic blood pressures, respectively.
Mortality. In multivariable-adjusted analyses, taking normotension as the reference, the HRs for total and cardiovascular mortality associated with diastolic (+5 mm Hg; Supplementary Table 3 ) and systolic (+10 mm Hg; Supplementary Table 4) blood pressures as measured by 24-hour daytime and nighttime monitoring did not differ significantly (P ≥ 0.13) from those in prehypertensive and hypertensive participants. The only exception was the higher HR for total mortality in relation to daytime diastolic blood pressure (DBP) in hypertensive compared with normotensive participants (1.10 vs. 0.92; P = 0.04).
Fatal combined with nonfatal endpoints. In multivariable-adjusted analyses, taking normotension as the reference, the HRs for the composite cardiovascular endpoint and cardiac events associated with diastolic (Table 3) and systolic (Table 4 ) blood pressures as measured by 24-hour daytime and nighttime monitoring did not significantly differ (P ≥ 0.19) from those in prehypertensive and hypertensive participants. However, the HRs for stroke associated with 24-hour and daytime DBPs were significantly (0.005 ≤ P ≤ 0.04) higher in normotensive participants than in prehypertensive and hypertensive participants. The estimates for 24-hour DBP were 1.98 vs.1.19 vs.1.28 and for the daytime DBP were 1.73 vs.1.09 vs.1.24, respectively (Table 3) . A similar trend (0.04 ≤ P ≤ 0.11) was observed for stroke in relation to the 24-hour and daytime systolic blood pressures (SBPs; 
Risk associated with masked hypertension
In the last step of our analyses, with sustained normotension as the reference (Figure 1 ), we first explored the HRs for the composite cardiovascular endpoint and stroke associated with masked hypertension, as defined on the basis of the daytime ABP. Among participants with normotension, 198 (7.5%) had masked hypertension because of an elevated daytime systolic (98 (49.5%)) or diastolic 63 (31.8%)) blood pressure or both (37 (18.7%)). Among participants with prehypertension, 900 (29.3%) had masked hypertension, because of an elevated daytime systolic (391 (43.4%)) or diastolic (216 (24.0%)) blood pressure or both (293 (32.6%)). Compared with true normotension, the HRs associated with masked hypertension in normotensive participants were 2.11 (95% CI, 1.24-3.60; P = 0.006) for a composite cardiovascular endpoint and 3.02 (95% CI, 1.25-7.32; P = 0.01) for stroke. The corresponding HRs associated with masked hypertension in prehypertensive participants were 2.08 (95% CI, 1.67-2.59; P < 0.0001) and 2.97 (95% CI, 2.03-4.35; P < 0.0001), respectively. The HRs associated with masked hypertension compared with true normotension were similar among normotensive and prehypertensive participants (P ≥ 0.75). Compared with prehypertension without masked hypertension, the HRs associated with masked hypertension in prehypertensive participants were 1.53 (95% CI, 1.23-1.91; P = 0.0001) for the composite cardiovascular endpoint and 1.48 (95% CI, 1.01-2.16; P = 0.04) for stroke ( Figure 1 ).
As shown in the Supplementary Results, the above findings were consistent if we defined masked hypertension based on the 24-hour (Supplementary Figure 1) or nighttime (Supplementary Figure 2) blood pressures. 
Sensitivity analyses
The incidence of endpoints differed among IDACO cohorts according to ethnicity, sex ratio, and age distribution. However, our results, which describe the risk of stroke associated with 24-hour (Supplementary Tables 6   and 8) or daytime (Supplementary Tables 7 and 9 ) DBP, remained consistent when we excluded 1 cohort at a time (Supplementary Tables 6 and 7 ) or in analyses stratified by sex, age (<60 vs. ≥60 years), or ethnicity (Supplementary  Tables 8 and 9 ). Abbreviations: HT, hypertension on conventional blood pressure measurement; NT, normotension on conventional blood pressure measurement; PHT, prehypertension on conventional blood pressure measurement.
NT (<120/<80 mm Hg), PHT (120-139/80-89 mm Hg), and HT (≥140/≥90 mm Hg) were defined according to the JNC7 2 /WHO-ISH 3 criteria. All rates increased from NT to PHT and from PHT to HT (P < 0.0001). Hazard ratios, presented with 95% confidence interval, express the risk compared with prehypertension. All Cox models were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular complications, and diabetes mellitus. Normotension (<120/<80 mm Hg), prehypertension (120-139/80-89 mm Hg), and hypertension (≥140/≥90 mm Hg) refer to the classification based on the conventional blood pressure according to the JNC7 2 /WHO-ISH 3 criteria. The number of participants and cardiovascular events per group appear in Table 2 . HRs, given with 95% CI, express the risk for a 5-mm Hg increase in diastolic blood pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular complications, and diabetes mellitus. P values are for the comparison of the HRs in prehypertensive and hypertensive participants with the HRs in normotensive participants. The differences in the HRs between prehypertensive and hypertensive participants were all nonsignificant (P ≥ 0.074).
Significance of the HRs: * P ≤ 0.05; † P ≤ 0.01, ‡ P ≤ 0.001, and § P ≤ 0.0001. Abbreviations: CI, confidence interval; HR, hazard ratio; ..., not applicable.
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DISCUSSION
Our current metaanalyses of patient-level data included 7,826 people not treated with blood pressure-lowering drugs. They were randomly recruited from 11 populations, and their follow-up covered, on average, 11.3 years. The key finding was that the relative risks associated with a higher ABP were similar across the 3 categories of the CBP for all endpoints under study with the exception of stroke. In normotensive and prehypertensive people with masked hypertension, the risk of cardiovascular events and stroke approximately doubled with each 10-mm Hg systolic or 5-mm Hg diastolic increase in ABP. We recently confirmed these findings in a patient-level metaanalysis of the International Database on Home blood pressure in relation to Cardiovascular Outcome using self-measured home blood pressure instead of ABP as the technique to assess the out-of-the-office blood pressure. 28 The replication of our current findings lends strong support Normotension (<120/<80 mm Hg), prehypertension (120-139/80-89 mm Hg), and hypertension (≥140/≥90 mm Hg) refer to the JNC classification based on the conventional blood pressure according to the JNC7 2 /WHO-ISH 3 criteria. The number of participants and cardiovascular events per group appear in Table 2 . HRs, given with 95% CI, express the risk for a 10-mm Hg increase in systolic blood pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular complications, and diabetes mellitus. P values are for the comparison of the HRs in prehypertensive and hypertensive participants with the HRs in normotensive participants. The differences in the HRs between prehypertensive and hypertensive participants were all nonsignificant (P ≥ 0.22).
Significance of the HRs: * P ≤ 0.05; † P ≤ 0.01, ‡ P ≤ 0.001, and § P ≤ 0.0001. Abbreviations: CI, confidence interval; HR, hazard ratio; ..., not applicable. to the concept that out-of-the-office blood pressure measurement should be applied in normotensive or prehypertensive people with suspected masked hypertension to screen for this high-risk condition. Using the daytime ABP, in our current study, out-of-the-office blood pressure unmasked masked hypertension in 7.5% and 29.3% of participants with normotension or prehypertension on CBP, respectively. However, in the absence of any trial evidence, one can only speculate about the number of events that can be prevented by the early treatment of this condition. Few other studies [7] [8] [9] [10] have addressed the association between health outcomes and the ABP across categories of the CBP, as proposed by US 2 and international 3 guidelines. Most studies were only cross-sectional 7, 8, 10 2, 3 The prevalence of prehypertension was 12.0%. Cardiovascular risk factors, including obesity and high pulse wave velocity, clustered in prehypertensive participants. 8 Manios and coworkers 10 enrolled 807 referred patients whose office blood pressure was <140 mm Hg systolic and 90 mm Hg diastolic. They applied the same criteria as we did to categorize their participants. The prevalence of pure prehypertension and prehypertension with masked hypertension was 59.9% and 19.7%, respectively. With adjustments applied, prehypertensive patients with masked hypertension had higher (P < 0.01) carotid intima-media thickness than prehypertensive patients without masked hypertension and normotensive patients (712 vs. 649 vs. 655 µm). Shimbo and colleagues 7 studied 813 untreated participants recruited from a worksite-based population study and obtained 9 blood pressure readings (3 at each of 3 visits over 3 weeks). Among 482 normotensive (<120/<80 mm Hg) and 287 prehypertensive (120-139/80-85 mm Hg) participants, the prevalence of masked hypertension was 3.9% and 34.1%, respectively. In multivariable-adjusted models, participants with prehypertension or masked hypertension (awake blood pressure ≥135/≥85 mm Hg) had greater left ventricular mass index than those with normotension (60.8 vs. 64.2 g/ m 2 ; P < 0.01), but left ventricular mass index was not different among prehypertensive participants without and with masked hypertension (66.1 vs. 68.6 g/m 2 ; P = 0.19).
Pierdomenico and colleagues 9 completed the only study that also investigated the incidence of cardiovascular events in prehypertensive patients with (n = 120) and without (n = 471) masked hypertension. The participants were hospital staff, patients referred for reasons other than cardiovascular disease or hypertension, and volunteers. During 6.6 years of follow-up (range, 0.5-15.5 years), 29 fatal and nonfatal cardiovascular events occurred. In prehypertensive patients without and with masked hypertension, the event rates per 100 patient-years were 0.57 and 1.51, respectively. With adjustments applied for covariables, including the CBP, Cox regression showed that cardiovascular risk was significantly higher in masked hypertension than in true prehypertension (masked vs. true prehypertension, relative risk 2.65; 95% CI, 1.18-5.98; P = 0.018). Prehypertension and masked hypertension carry great risk to develop into hypertension. In the Flemish Study on Environment, Genes and Health Outcomes, 30 the 4-year progression rates from prehypertension to hypertension were 17.9% and 26.3% in participants aged <50 years and those aged ≥50 years, respectively. In the Copenhagen Monitoring of Trends and Determinants in Cardiovascular Disease, 31 the progression rate over 10 years was 37.3%. In multivariable-adjusted analyses, progression to prehypertension or to hypertension was associated with 10-year cardiovascular risks of 11.1% and 13.9%, respectively. 31 We 5,32 and other investigators [33] [34] [35] demonstrated that masked hypertension carries a risk approaching that of sustained hypertension. However, the novel finding of our current study is that ABP monitoring contributes to risk stratification in people who, on the basis of their CBP, would be categorized as being at low cardiovascular risk and that masked hypertension is the driver of this risk. The present findings therefore suggest that screening for masked hypertension among prehypertensive and even normotensive people might be useful. The relationship between the cardiovascular and renal complications driven by blood pressure is continuous, at least down to a CBP level of 115 mm Hg systolic or 75 mm Hg diastolic. 1 Stroke is the complication of hypertension most closely associated with blood pressure. 36 The continuous nature of the relation with blood pressure not only holds true in hypertensive patients but in normotensive people as well. 1, 37 Our current findings clearly show that the relative risk of stroke increases with the ABP in normotensive people at twice the rate observed in patients with hypertension. In addition, we demonstrated that masked hypertension in normotensive and prehypertensive patients contributes to the risk of stroke and cardiovascular complications. Our current findings suggest that ABP monitoring might be indicated in normotensive and prehypertensive people to screen for masked hypertension, a condition that confers a risk approaching that of sustained hypertension. 5 Our current data and the literature show that men, prehypertensive patients, diabetic patients, 32 smokers, 38 alcohol consumers, and individuals with increased cholesterol (≥5.7 mmol/L) are at increased risk of having masked hypertension. However, robust evidence for the routine implementation of ABP monitoring as a screening tool for masked hypertension should come from randomized clinical trials that prove that the early diagnosis of masked hypertension and treatment of this condition reduces the incidence of cardiovascular events.
The strong points of our current study are the use of ambulatory monitoring to assess blood pressure; the relatively large sample size, representing populations from Europe, Asia, and South America; and the removal of treated participants from the analysis. Nevertheless, our study also has limitations. First, the number of strokes was relatively low, so that estimates of stroke risk might be less precise than wished for. We could not differentiate between ischemic and hemorrhagic stroke. On the other hand, the probability of detecting a relation with a predictor variable increases with at KU Leuven University Library on http://ajh.oxfordjournals.org/ Downloaded from the number of events. Thus, that we could already detect a statistically significant difference between normotensive and hypertensive participants in the HRs for stroke associated with the ABP might reflect a true and very strong underlying relation in normotensive people. Second, we did not determine the reproducibility of masked hypertension in the context of our current population study. However, Viera and colleagues reported prevalence rates of masked hypertension among untreated patients with a borderline elevated office blood pressure to be 54% and 53% on first and repeat assessment with an agreement of 73%. 39 Among patients who underwent repeat ambulatory monitoring for a medical indication, Ben-Dov and coworkers reported an agreement of 72%. 40 Third, most participants had their CBP measured while seated at an examination center. By contrast, in other cohorts the CBP was measured in the supine position 15 or at home. 14, [17] [18] [19] Fourth, ABP monitoring was not standardized in terms of device type and intervals between successive readings, but the same SAS macro ensured that daytime was always defined in the same fashion, using short fixed clocktime intervals, 41 and that the time-weighted means were calculated identically across cohorts. Finally, binning a continuous variable such as the CBP is deemed to lose information. 42 However, we followed the categorization proposed by guidelines 2, 3 for use in clinical practice and to be indiscriminately applied to adults of both sexes across the age range.
In conclusion, ABP monitoring contributes to risk stratification in normotension and prehypertension, particularly in the presence of masked hypertension. Further research should address the question whether ABP monitoring might be a cost-effective screening technique to prevent the cardiovascular complications associated with masked hypertension in patients with prehypertension 23 or even in normotensive people in whom unexplained target organ damage is present or who accumulate characteristics often associated with masked hypertension (Supplementary Results).
SUPPLEMENTARY MATERIAL
Supplementary materials are available at American Journal of Hypertension (http://ajh.oxfordjournals.org).
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EXPANDED METHODS
Study population
As described in detail elsewhere, 1 we constructed the International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO). Studies were eligible for inclusion, if they involved a random population sample, if baseline information on the ambulatory blood pressure and cardiovascular risk factors was available, and if the subsequent follow-up included both fatal and nonfatal outcomes. Details on the recruitment of participants appear in Table S1 and on the quality of the ambulatory blood pressure recordings in the Supplementary Materials associated with a recent IDACO publication. 2 In the current study, analyzed participants were 1823 residents from Copenhagen, Denmark; 3 851 inhabitants from Ohasama, Japan; 4 1175 subjects from Noorderkempen, Belgium; 5 713 older men from Uppsala, Sweden; 6 1188 subjects from Montevideo, Uruguay; 7 299 villagers from the Jingning County, China; 8 204 subjects from Novosibirsk, the Russian Federation; 9 133 from Pilsen, Czech Republic; 10 930 from Dublin, Ireland; 11 266 from Padua, Italy; 10 and 244 from Kraków, Poland. 10 All participants gave informed written consent.
Subjects recruited in Kraków, Novosibirsk, Pilsen, and Padova took part in the European Project on Genes in Hypertension (EPOGH). 10 All participants gave informed written consent.
Blood pressure measurement
Conventional blood pressure was measured by trained observers with a mercury sphygmomanometer, 8, [10] [11] [12] with validated auscultatory 4 (USM-700F, UEDA Electronic Works, Tokyo, Japan) or oscillometric 7 (OMRON HEM-705CP, Omron Corporation, Tokyo, Japan) devices, using the appropriate cuff size, with participants in the sitting 4, 5, [7] [8] [9] [10] [11] [12] or supine 6 position.
Conventional blood pressure was the average of two consecutive readings obtained either at Risk stratification by CBP and ABP -s3-the person's home 5, [7] [8] [9] [10] or at an examination center. 4, 6, 11, 12 We programmed portable monitors to obtain ambulatory blood pressure readings at 30-minute intervals throughout the whole day, 4, 11 or at intervals ranging from 15minutes 12 to 30 minutes 6 during daytime and from 30 minutes 12 to 60 minutes 6 at night. The devices implemented an auscultatory algorithm (Accutracker II) in Uppsala 6 or an oscillometric technique (SpaceLabs 90202 and 90207, Nippon Colin, and ABPM 630) in the other cohorts. [4] [5] [6] [7] [8] [9] [10] [11] The same SAS macro processed all ambulatory recordings, which generally remained unedited. The Ohasama recordings were edited sparsely according to previously published criteria. 13 Within individual subjects, we weighted the means of the ambulatory blood pressure by the interval between readings. When accounting for the daily pattern of activities of the participants, we defined daytime as the interval ranging from 1000 h to 2000 h in people from Europe 5,6,9-12 and South America, 7 and from 0800 h to 1800 h in Asians. 4, 8 The corresponding nighttime intervals ranged from midnight to 0600 h 5-7,9-12 and from 2200 h to 0400 h. 4, 8 These fixed time intervals eliminate the transition periods in the morning and evening when blood pressure changes rapidly, resulting in daytime and nighttime blood pressure levels that are within 1-2 mm Hg of the awake and asleep levels. 8, 14 We categorized conventional blood pressure according to the JNC7 15 and WHO-ISH 16 guidelines. Normal blood pressure was a level lower than 120 mm Hg systolic and 80 mm Hg diastolic. High-normal blood pressure encompassed 120 to 139 mm Hg systolic or 80 to 89 mm Hg diastolic. Patients who had a blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic were classified as hypertensive. To categorize levels of the ambulatory blood pressure, we followed the guidelines of the European Societies of Cardiology and Hypertension. 17 Ambulatory hypertension was a 24-h level of at least 130 mm Hg systolic or 80 mm Hg diastolic; for the daytime blood pressure these thresholds were 135 mm Hg and 85 mm Hg, and for the nighttime blood pressure 120 mm Hg and 70 mm Hg, respectively.
Correlates of masked hypertension
Based on previous research, 18 we evaluated sex, age, body mass index, the level of the conventionally measured systolic and diastolic blood pressure, current smoking and drinking, serum cholesterol, history of cardiovascular complications and diabetes mellitus as potential determinants of masked hypertension. We modeled these variables using single and multivariable logistic regression. We estimated the performance of variables to differentiate between individuals with and without masked hypertension, using sensitivity, specificity, the misclassification rate and the area under the receiver operating characteristic curve. We applied Younden's index to determine the optimal discrimination limit for continuous correlates.
The difference in the HRs associated with the ABP analyzed as a continuous variable between participants belonging to different CBP categories was tested by introducing the product term between CBP category (binary variable) and ABP (continuous variable) along with the other covariables in models including the two group to be compared (normotension vs. prehypertension and prehypertension vs. hypertension).
SUPPLEMENTARY RESULTS
Correlates of masked hypertension
In both single (Table S1 ) and multiple (Table S2 ) logistic regression analysis, male sex, older age, higher body mass index, serum cholesterol and higher conventional systolic and diastolic blood pressure, history of diabetes mellitus and current smoking and alcohol intake correlated with masked hypertension in participants with a conventional blood pressure be- Table 2 . Hazard ratios (HRs), given with 95% confidence interval (CI) express the risk for a 5-mm Hg increase in diastolic blood pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular complications, and diabetes mellitus. P values are for the comparison of the HRs in prehypertensive and hypertensive participants with the HRs in normotensive subjects. The differences in the HRs between prehypertensive and hypertensive participants were all nonsignificant (P  0.10) with the exception of total mortality in relation to daytime diastolic blood pressure (P = 0.04). Significance of the hazard ratios: † P  0.01, ‡ P  0.001, and § P  0.0001. Table 2 . Hazard ratios (HRs), given with 95% confidence interval (CI) express the risk for a 10-mm Hg increase in systolic blood pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular complications, and diabetes mellitus. P values are for the comparison of the HRs in prehypertensive and hypertensive participants with the HRs in normotensive subjects. The differences in the HRs between prehypertensive and hypertensive participants were all nonsignificant (P  0.37). Significance of the hazard ratios: * P  0.05; † P  0.01, ‡ P  0.001, and § P  0.0001. 
